{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T13:18:56Z","timestamp":1786972736707,"version":"build-2736575974"},"reference-count":48,"publisher":"Federa\u00e7\u00e3o das Associa\u00e7\u00f5es de Ginecologia e Obstetr\u00edcia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,18]]},"DOI":"10.61622\/rbgo\/2025rbgo86","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T21:36:58Z","timestamp":1763501818000},"source":"Crossref","is-referenced-by-count":1,"title":["The combination of circulating levels of ANGPTL, omentin-1, leptin and cytokines is associated with polycystic ovary syndrome in different BMI groups"],"prefix":"10.61622","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6717-7682","authenticated-orcid":false,"given":"Rumeysa","family":"\u00c7\u0131nar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9249-679X","authenticated-orcid":false,"given":"\u00d6zlem Kayac\u0131k","family":"G\u00fcnday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3310-3252","authenticated-orcid":false,"given":"Ahmet","family":"Kahraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5445-6159","authenticated-orcid":false,"given":"Mehmet","family":"Y\u0131lmazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"47794","reference":[{"issue":"12","key":"key20251118213653_B1","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","unstructured":"Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016;31(12):2841-55. doi: 10.1093\/humrep\/dew218","journal-title":"Hum Reprod"},{"key":"key20251118213653_B2","doi-asserted-by":"crossref","first-page":"719050","DOI":"10.1155\/2014\/719050","article-title":"Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth","volume":"2014","author":"Rojas","year":"2014","unstructured":"Rojas J, Ch\u00e1vez M, Olivar L, Rojas M, Morillo J, Mej\u00edas J, et al. Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth. Int J Reprod Med. 2014;2014:719050. doi: 10.1155\/2014\/719050","journal-title":"Int J Reprod Med"},{"issue":"6","key":"key20251118213653_B3","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/humupd\/dms030","article-title":"Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"18","author":"Lim","year":"2012","unstructured":"Lim SS, Davies MJ, Norman RJ, Moran LJ. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2012;18(6):618-37. doi: 10.1093\/humupd\/dms030","journal-title":"Hum Reprod Update"},{"issue":"6","key":"key20251118213653_B4","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1210\/jc.2002-022033","article-title":"Adiponectin levels in women with polycystic ovary syndrome","volume":"88","author":"Orio","year":"2003","unstructured":"Orio F Jr, Palomba S, Cascella T, Milan G, Mioni R, Pagano C, et al. Adiponectin levels in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003;88(6):2619-23. doi: 10.1210\/jc.2002-022033","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"key20251118213653_B5","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1017\/S0007114520003207","article-title":"Influence of n-3 fatty acid supplementation on inflammatory and oxidative stress markers in patients with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"125","author":"Tosatti","year":"2021","unstructured":"Tosatti JA, Alves MT, C\u00e2ndido AL, Reis FM, Ara\u00fajo VE, Gomes KB. Influence of n-3 fatty acid supplementation on inflammatory and oxidative stress markers in patients with polycystic ovary syndrome: a systematic review and meta-analysis. Br J Nutr. 2021;125(6):657-68. doi: 10.1017\/S0007114520003207","journal-title":"Br J Nutr"},{"issue":"3","key":"key20251118213653_B6","doi-asserted-by":"crossref","first-page":"1048.e1-2","DOI":"10.1016\/j.fertnstert.2010.11.036","article-title":"Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis","volume":"95","author":"Escobar-Morreale","year":"2011","unstructured":"Escobar-Morreale HF, Luque-Ram\u00edrez M, Gonz\u00e1lez F. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril. 2011;95(3):1048-58.e1-2. doi: 10.1016\/j.fertnstert.2010.11.036","journal-title":"Fertil Steril"},{"issue":"1","key":"key20251118213653_B7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s40618-015-0335-2","article-title":"The mean platelet volume and neutrophil to lymphocyte ratio in obese and lean patients with polycystic ovary syndrome","volume":"39","author":"Yilmaz","year":"2016","unstructured":"Yilmaz MA, Duran C, Basaran M. The mean platelet volume and neutrophil to lymphocyte ratio in obese and lean patients with polycystic ovary syndrome. J Endocrinol Invest. 2016;39(1):45-53. doi: 10.1007\/s40618-015-0335-2","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"key20251118213653_B8","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1210\/jc.2003-030178","article-title":"The potential influence of inflammation and insulin resistance on the pathogenesis and treatment of atherosclerosis-related complications in type 2 diabetes","volume":"88","author":"Dandona","year":"2003","unstructured":"Dandona P, Aljada A, Chaudhuri A, Bandyopadhyay A. The potential influence of inflammation and insulin resistance on the pathogenesis and treatment of atherosclerosis-related complications in type 2 diabetes. J Clin Endocrinol Metab. 2003;88(6):2422-9. doi: 10.1210\/jc.2003-030178","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key20251118213653_B9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s12020-015-0838-9","article-title":"The role of ANGPTL3 in controlling lipoprotein metabolism","volume":"52","author":"Tikka","year":"2016","unstructured":"Tikka A, Jauhiainen M. The role of ANGPTL3 in controlling lipoprotein metabolism. Endocrine. 2016;52(2):187-93. doi: 10.1007\/s12020-015-0838-9","journal-title":"Endocrine"},{"issue":"3","key":"key20251118213653_B10","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tem.2013.12.005","article-title":"Regulation of lipoprotein lipase by Angptl4","volume":"25","author":"Dijk","year":"2014","unstructured":"Dijk W, Kersten S. Regulation of lipoprotein lipase by Angptl4. Trends Endocrinol Metab. 2014;25(3):146-55. doi: 10.1016\/j.tem.2013.12.005","journal-title":"Trends Endocrinol Metab"},{"issue":"7","key":"key20251118213653_B11","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1161\/ATVBAHA.113.301698","article-title":"Overexpression of angiopoietin-like protein 4 protects against atherosclerosis development","volume":"33","author":"Georgiadi","year":"2013","unstructured":"Georgiadi A, Wang Y, Stienstra R, Tjeerdema N, Janssen A, Stalenhoef A, et al. Overexpression of angiopoietin-like protein 4 protects against atherosclerosis development. Arterioscler Thromb Vasc Biol. 2013;33(7):1529-37. doi: 10.1161\/ATVBAHA.113.301698","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"key20251118213653_B12","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.bbrc.2012.07.038","article-title":"Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels","volume":"424","author":"Zhang","year":"2012","unstructured":"Zhang R. Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels. Biochem Biophys Res Commun. 2012;424(4):786-92. doi: 10.1016\/j.bbrc.2012.07.038","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"key20251118213653_B13","first-page":"903","article-title":"Examination of angiopoietin-like protein 4, neuropeptide Y, omentin-1 levels of obese and non-obese patients with polycystic ovary syndrome","volume":"31","author":"G\u00fcne\u015f","year":"2015","unstructured":"G\u00fcne\u015f M, Bukan N. Examination of angiopoietin-like protein 4, neuropeptide Y, omentin-1 levels of obese and non-obese patients with polycystic ovary syndrome. Gynecol Endocrinol. 2015;31(11):903-6. doi.org\/: 10.3109\/09513590.2015.1068285","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"key20251118213653_B14","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2310\/JIM.0b013e31824e9900","article-title":"Serum levels of angiopoietin-related growth factor (AGF) are increased in polycystic ovary syndrome","volume":"60","author":"Boztosun","year":"2012","unstructured":"Boztosun A, Deveci K, Kl\u00e7l F, S\u00f6ylemez MS, Muhtaro\u011flu S, M\u00fcderris, II. Serum levels of angiopoietin-related growth factor (AGF) are increased in polycystic ovary syndrome. J Investig Med. 2012;60(5):813-7. doi: 10.2310\/JIM.0b013e31824e9900","journal-title":"J Investig Med"},{"issue":"1","key":"key20251118213653_B15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s12020-016-0875-z","article-title":"Elevated circulating levels of betatrophin are associated with polycystic ovary syndrome","volume":"53","author":"Calan","year":"2016","unstructured":"Calan M, Yilmaz O, Kume T, Unal Kocabas G, Yesil Senses P, Senses YM, et al. Elevated circulating levels of betatrophin are associated with polycystic ovary syndrome. Endocrine. 2016;53(1):271-9. doi: 10.1007\/s12020-016-0875-z","journal-title":"Endocrine"},{"key":"key20251118213653_B16","doi-asserted-by":"crossref","first-page":"118595","DOI":"10.1016\/j.lfs.2020.118595","article-title":"Evaluation of angiopoietin-like protein 3 (ANGPTL3) levels in polycystic ovary syndrome","volume":"263","author":"Vatannejad","year":"2020","unstructured":"Vatannejad A, Salimi F, Moradi N, Fouani FZ, Zandieh Z, Ansaripour S, et al. Evaluation of angiopoietin-like protein 3 (ANGPTL3) levels in polycystic ovary syndrome. Life Sci. 2020;263:118595. doi: 10.1016\/j.lfs.2020.118595","journal-title":"Life Sci"},{"key":"key20251118213653_B17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.metabol.2018.11.005","article-title":"Obesity and dyslipidemia","volume":"92","author":"Vekic","year":"2019","unstructured":"Vekic J, Zeljkovic A, Stefanovic A, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V. Obesity and dyslipidemia. Metabolism. 2019;92:71-81. doi: 10.1016\/j.metabol.2018.11.005","journal-title":"Metabolism"},{"issue":"3","key":"key20251118213653_B18","doi-asserted-by":"crossref","first-page":"324","DOI":"10.4103\/2230-8210.180005","article-title":"Leptin and body mass index in polycystic ovary syndrome","volume":"20","author":"Jalilian","year":"2016","unstructured":"Jalilian N, Haghnazari L, Rasolinia S. Leptin and body mass index in polycystic ovary syndrome. Indian J Endocrinol Metab. 2016;20(3):324-8. doi: 10.4103\/2230-8210.180005","journal-title":"Indian J Endocrinol Metab"},{"key":"key20251118213653_B19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1475-2840-6-7","article-title":"Plasma levels of leptin, omentin, collagenous repeat-containing sequence of 26-kDa protein (CORS-26) and adiponectin before and after oral glucose uptake in slim adults","volume":"6","author":"Wurm","year":"2007","unstructured":"Wurm S, Neumeier M, Weigert J, Sch\u00e4ffler A, Buechler C. Plasma levels of leptin, omentin, collagenous repeat-containing sequence of 26-kDa protein (CORS-26) and adiponectin before and after oral glucose uptake in slim adults. Cardiovasc Diabetol. 2007;6:7. doi: 10.1186\/1475-2840-6-7","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"key20251118213653_B20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000319508","article-title":"Expression of neuropeptide Y, omentin and visfatin in visceral and subcutaneous adipose tissues in humans: relation to endocrine and clinical parameters","volume":"3","author":"Barth","year":"2010","unstructured":"Barth S, Klein P, Horbach T, D\u00f6tsch J, Rauh M, Rascher W, et al. Expression of neuropeptide Y, omentin and visfatin in visceral and subcutaneous adipose tissues in humans: relation to endocrine and clinical parameters. Obes Facts. 2010;3(4):245-51. doi: 10.1159\/000319508","journal-title":"Obes Facts"},{"issue":"2","key":"key20251118213653_B21","first-page":"108","article-title":"Study of omentin1 and other adipokines and hormones in PCOS patients","volume":"24","author":"Mahde","year":"2009","unstructured":"Mahde A, Shaker M, Al-Mashhadani Z. Study of omentin1 and other adipokines and hormones in PCOS patients. Oman Med J. 2009;24(2):108-18. doi: 10.5001\/omj.2009.25","journal-title":"Oman Med J"},{"issue":"10","key":"key20251118213653_B22","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1016\/j.transproceed.2013.08.097","article-title":"Body composition analysis of patients on waiting list for cadaveric renal transplantation: a comparison of hemodialysis and peritoneal dialysis patients","volume":"45","author":"Bal","year":"2013","unstructured":"Bal Z, Uyar ME, Tutal E, Guliyev O, Sezer S, Haberal M. Body composition analysis of patients on waiting list for cadaveric renal transplantation: a comparison of hemodialysis and peritoneal dialysis patients. Transplant Proc. 2013;45(10):3489-93. doi: 10.1016\/j.transproceed.2013.08.097","journal-title":"Transplant Proc"},{"issue":"10","key":"key20251118213653_B23","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"108","author":"Teede","year":"2023","unstructured":"Teede HJ, Tay CT, Laven JJ, Dokras A, Moran LJ, Piltonen TT, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. J Clin Endocrinol Metab. 2023;108(10):2447-69. doi: 10.1210\/clinem\/dgad463","journal-title":"J Clin Endocrinol Metab"},{"key":"key20251118213653_B24","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferriman","year":"1961","unstructured":"Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961;21:1440-7. doi: 10.1210\/jcem-21-11-1440","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key20251118213653_B25","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1080\/09513590.2018.1536736","article-title":"Circulating angiopoietin-like 8 protein (ANGPTL8\/Betatrophin) in patients with polycystic ovary syndrome: a systematic review and multi effect size meta-analysis","volume":"35","author":"Varikasuvu","year":"2019","unstructured":"Varikasuvu SR, Panga JR, Satyanarayana MV. Circulating angiopoietin-like 8 protein (ANGPTL8\/Betatrophin) in patients with polycystic ovary syndrome: a systematic review and multi effect size meta-analysis. Gynecol Endocrinol. 2019;35(3):190-7. doi: 10.1080\/09513590.2018.1536736","journal-title":"Gynecol Endocrinol"},{"issue":"9","key":"key20251118213653_B26","first-page":"969","article-title":"[Elevated serum levels of betatrophin in patients with polycystic ovary syndrome and the influential factors]","volume":"41","author":"Song","year":"2016","unstructured":"Song S, Wang J, Guo C, Jiang T. [Elevated serum levels of betatrophin in patients with polycystic ovary syndrome and the influential factors]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2016;41(9):969-74. doi: 10.11817\/j.issn.1672-7347.2016.09.012. Chinese.","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"issue":"2","key":"key20251118213653_B27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/09513590.2016.1223286","article-title":"Novel adipokines WISP1 and betatrophin in PCOS: relationship to AMH levels, atherogenic and metabolic profile","volume":"33","author":"Sahin Ersoy","year":"2017","unstructured":"Sahin Ersoy G, Altun Ensari T, Vatansever D, Emirdar V, Cevik O. Novel adipokines WISP1 and betatrophin in PCOS: relationship to AMH levels, atherogenic and metabolic profile. Gynecol Endocrinol. 2017;33(2):119-23. doi: 10.1080\/09513590.2016.1223286","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"key20251118213653_B28","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/01443615.2017.1286464","article-title":"Assessment of circulating betatrophin concentrations in lean glucose-tolerant women with polycystic ovary syndrome","volume":"37","author":"Erol","year":"2017","unstructured":"Erol O, \u00d6zel MK, Ellida\u011f HY, Topta\u015f T, Derbent AU, Y\u0131lmaz N. Assessment of circulating betatrophin concentrations in lean glucose-tolerant women with polycystic ovary syndrome. J Obstet Gynaecol. 2017;37(5):633-8. doi: 10.1080\/01443615.2017.1286464","journal-title":"J Obstet Gynaecol"},{"issue":"5","key":"key20251118213653_B29","first-page":"20","article-title":"Relationship between betatrophin levels and metabolic parameters in patients with polycystic ovary syndrome","volume":"62","author":"Erbag","year":"2016","unstructured":"Erbag G, Eroglu M, Turkon H, Sen H, Binnetoglu E, Aylanc N, et al. Relationship between betatrophin levels and metabolic parameters in patients with polycystic ovary syndrome. Cell Mol Biol (Noisy-le-grand). 2016;62(5):20-4.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"1","key":"key20251118213653_B30","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1038\/s41467-018-04611-z","article-title":"Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetes","volume":"9","author":"Gusarova","year":"2018","unstructured":"Gusarova V, O\u2019Dushlaine C, Teslovich TM, Benotti PN, Mirshahi T, Gottesman O, et al. Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetes. Nat Commun. 2018;9(1):2252. doi: 10.1038\/s41467-018-04611-z","journal-title":"Nat Commun"},{"issue":"4","key":"key20251118213653_B31","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.2337\/db13-1435","article-title":"Elevated mouse hepatic betatrophin expression does not increase human \u03b2-cell replication in the transplant setting","volume":"63","author":"Jiao","year":"2014","unstructured":"Jiao Y, Le Lay J, Yu M, Naji A, Kaestner KH. Elevated mouse hepatic betatrophin expression does not increase human \u03b2-cell replication in the transplant setting. Diabetes. 2014;63(4):1283-8. doi: 10.2337\/db13-1435","journal-title":"Diabetes"},{"issue":"3","key":"key20251118213653_B32","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1080\/09513590.2018.1519791","article-title":"Serum betatrophin levels are reduced in patients with full-blown polycystic ovary syndrome","volume":"35","author":"Eksi Haydardedeoglu","year":"2019","unstructured":"Eksi Haydardedeoglu F, Bagir GS, Haydardedeoglu B, Bozkirli E, Bakiner O, Metin K, et al. Serum betatrophin levels are reduced in patients with full-blown polycystic ovary syndrome. Gynecol Endocrinol. 2019;35(3):224-7. doi: 10.1080\/09513590.2018.1519791","journal-title":"Gynecol Endocrinol"},{"key":"key20251118213653_B33","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.2147\/DMSO.S455274","article-title":"Association Between rs2278426 Polymorphism of the ANGPTL8 Gene and Polycystic Ovary Syndrome","volume":"17","author":"Wu","year":"2024","unstructured":"Wu H, Wang H, Sun L, Liu M, Wang H, Sun X, et al. Association Between rs2278426 Polymorphism of the ANGPTL8 Gene and Polycystic Ovary Syndrome. Diabetes Metab Syndr Obes. 2024;17:1749-60. doi: 10.2147\/DMSO.S455274","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"8","key":"key20251118213653_B34","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1080\/09513590.2020.1725964","article-title":"Serum betatrophin levels are significantly increased in obese patients compared to lean patients regardless to the presence of PCOS","volume":"36","author":"Keyif","year":"2020","unstructured":"Keyif B, Goksever Celik H, Karamustafaoglu Balci B, Mehves Celebi M, Ozaltin S, Takmaz O, et al. Serum betatrophin levels are significantly increased in obese patients compared to lean patients regardless to the presence of PCOS. Gynecol Endocrinol. 2020;36(8):678-81. doi: 10.1080\/09513590.2020.1725964","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"key20251118213653_B35","first-page":"39","article-title":"Angiopoietin-Like 3 (ANGPTL3) and atherosclerosis: lipid and non-lipid related effects","volume":"5","author":"Lupo","year":"2018","unstructured":"Lupo MG, Ferri N. Angiopoietin-Like 3 (ANGPTL3) and atherosclerosis: lipid and non-lipid related effects. J Cardiovasc Dev Dis. 2018;5(3):39. doi: 10.3390\/jcdd5030039","journal-title":"J Cardiovasc Dev Dis"},{"issue":"1","key":"key20251118213653_B36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12944-016-0337-x","article-title":"Increased ANGPTL3, 4 and ANGPTL8\/betatrophin expression levels in obesity and T2D","volume":"15","author":"Abu-Farha","year":"2016","unstructured":"Abu-Farha M, Al-Khairi I, Cherian P, Chandy B, Sriraman D, Alhubail A, et al. Increased ANGPTL3, 4 and ANGPTL8\/betatrophin expression levels in obesity and T2D. Lipids Health Dis. 2016;15(1):181. doi: 10.1186\/s12944-016-0337-x","journal-title":"Lipids Health Dis"},{"issue":"1","key":"key20251118213653_B37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41387-018-0032-2","article-title":"Angiopoietin-like protein 3 and 4 in obesity, type 2 diabetes mellitus, and malnutrition: the effect of weight reduction and realimentation","volume":"8","author":"Cinkajzlov\u00e1","year":"2018","unstructured":"Cinkajzlov\u00e1 A, Mr\u00e1z M, Lacinov\u00e1 Z, Klou\u010dkov\u00e1 J, Kav\u00e1lkov\u00e1 P, Kratochv\u00edlov\u00e1 H, et al. Angiopoietin-like protein 3 and 4 in obesity, type 2 diabetes mellitus, and malnutrition: the effect of weight reduction and realimentation. Nutr Diabetes. 2018;8(1):21. doi: 10.1038\/s41387-018-0032-2","journal-title":"Nutr Diabetes"},{"key":"key20251118213653_B38","doi-asserted-by":"crossref","first-page":"799833","DOI":"10.3389\/fendo.2021.799833","article-title":"ANGPTL4 expression in ovarian granulosa cells \u0131s associated with polycystic ovary syndrome","volume":"12","author":"Jiang","year":"2021","unstructured":"Jiang Q, Pan Y, Li P, Zheng Y, Bian Y, Wang W, et al. ANGPTL4 expression in ovarian granulosa cells \u0131s associated with polycystic ovary syndrome. Front Endocrinol (Lausanne). 2021;12:799833. doi: 10.3389\/fendo.2021.799833","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"key20251118213653_B39","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1530\/EJE-11-0375","article-title":"Plasma omentin-1 levels are reduced in non-obese women with normal glucose tolerance and polycystic ovary syndrome","volume":"165","author":"Choi","year":"2011","unstructured":"Choi JH, Rhee EJ, Kim KH, Woo HY, Lee WY, Sung KC. Plasma omentin-1 levels are reduced in non-obese women with normal glucose tolerance and polycystic ovary syndrome. Eur J Endocrinol. 2011;165(5):789-96. doi: 10.1530\/EJE-11-0375","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"key20251118213653_B40","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/cen.12381","article-title":"Plasma omentin and adiponectin levels as markers of adipose tissue dysfunction in normal weight and obese women with polycystic ovary syndrome","volume":"81","author":"Orlik","year":"2014","unstructured":"Orlik B, Madej P, Owczarek A, Ska\u0142ba P, Chudek J, Olszanecka-Glinianowicz M. Plasma omentin and adiponectin levels as markers of adipose tissue dysfunction in normal weight and obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 2014;81(4):529-35. doi: 10.1111\/cen.12381","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"key20251118213653_B41","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2337\/db07-0990","article-title":"Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose","volume":"57","author":"Tan","year":"2008","unstructured":"Tan BK, Adya R, Farhatullah S, Lewandowski KC, O\u2019Hare P, Lehnert H, et al. Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose. Diabetes. 2008;57(4):801-8. doi: 10.2337\/db07-0990","journal-title":"Diabetes"},{"issue":"6","key":"key20251118213653_B42","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s13224-021-01510-0","article-title":"Association of leptin with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"71","author":"Seth","year":"2021","unstructured":"Seth MK, Gulati S, Gulati S, Kumar A, Rawat D, Kumari A, et al. Association of leptin with polycystic ovary syndrome: a systematic review and meta-analysis. J Obstet Gynaecol India. 2021;71(6):567-76. doi: 10.1007\/s13224-021-01510-0","journal-title":"J Obstet Gynaecol India"},{"key":"key20251118213653_B43","doi-asserted-by":"crossref","first-page":"845165","DOI":"10.3389\/fendo.2022.845165","article-title":"Elevated serum leptin levels as a predictive marker for polycystic ovary syndrome","volume":"13","author":"Peng","year":"2022","unstructured":"Peng Y, Yang H, Song J, Feng D, Na Z, Jiang H, et al. Elevated serum leptin levels as a predictive marker for polycystic ovary syndrome. Front Endocrinol (Lausanne). 2022;13:845165. doi: 10.3389\/fendo.2022.845165","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"key20251118213653_B44","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1007\/s00125-014-3208-x","article-title":"Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals","volume":"57","author":"Fenzl","year":"2014","unstructured":"Fenzl A, Itariu BK, Kosi L, Fritzer-Szekeres M, Kautzky-Willer A, Stulnig TM, et al. Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals. Diabetologia. 2014;57(6):1204-8. doi: 10.1007\/s00125-014-3208-x","journal-title":"Diabetologia"},{"issue":"10","key":"key20251118213653_B45","doi-asserted-by":"crossref","first-page":"E2004","DOI":"10.1210\/jc.2014-1568","article-title":"Circulating betatrophin concentrations are decreased in human obesity and type 2 diabetes","volume":"99","author":"G\u00f3mez-Ambrosi","year":"2014","unstructured":"G\u00f3mez-Ambrosi J, Pascual E, Catal\u00e1n V, Rodr\u00edguez A, Ram\u00edrez B, Silva C, et al. Circulating betatrophin concentrations are decreased in human obesity and type 2 diabetes. J Clin Endocrinol Metab. 2014;99(10):E2004-9. doi: 10.1210\/jc.2014-1568","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"key20251118213653_B46","doi-asserted-by":"crossref","first-page":"E1188","DOI":"10.1210\/JC.2015-1595","article-title":"Circulating betatrophin levels are \u0131ncreased in anorexia and decreased in morbidly obese women","volume":"100","author":"Barja-Fern\u00e1ndez","year":"2015","unstructured":"Barja-Fern\u00e1ndez S, Folgueira C, Seoane LM, Casanueva FF, Dieguez C, Castelao C, et al. Circulating betatrophin levels are \u0131ncreased in anorexia and decreased in morbidly obese women. J Clin Endocrinol Metab. 2015;100(9):E1188-96. doi: 10.1210\/JC.2015-1595","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"key20251118213653_B47","doi-asserted-by":"crossref","first-page":"E96","DOI":"10.1210\/jc.2014-2300","article-title":"Circulating betatrophin levels are increased in patients with type 2 diabetes and associated with insulin resistance","volume":"100","author":"Chen","year":"2015","unstructured":"Chen X, Lu P, He W, Zhang J, Liu L, Yang Y, et al. Circulating betatrophin levels are increased in patients with type 2 diabetes and associated with insulin resistance. J Clin Endocrinol Metab. 2015;100(1):E96-100. doi: 10.1210\/jc.2014-2300","journal-title":"J Clin Endocrinol Metab"},{"key":"key20251118213653_B48","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13098-015-0019-2","article-title":"Associations of betatrophin levels with irisin in Chinese women with normal glucose tolerance","volume":"7","author":"Xie","year":"2015","unstructured":"Xie X, Gao T, Yang M, Chen P, Jin H, Yang L, et al. Associations of betatrophin levels with irisin in Chinese women with normal glucose tolerance. Diabetol Metab Syndr. 2015;7:26. doi: 10.1186\/s13098-015-0019-2","journal-title":"Diabetol Metab Syndr"}],"container-title":["Revista Brasileira de Ginecologia e Obstetr\u00edcia"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T21:37:03Z","timestamp":1763501823000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalrbgo.org\/article\/the-combination-of-circulating-levels-of-angptl-omentin-1-leptin-and-cytokines-is-associated-with-polycystic-ovary-syndrome-in-different-bmi-groups\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":48,"alternative-id":["10.61622\/rbgo\/2025rbgo86"],"URL":"https:\/\/doi.org\/10.61622\/rbgo\/2025rbgo86","relation":{},"ISSN":["0100-7203","1806-9339"],"issn-type":[{"value":"0100-7203","type":"print"},{"value":"1806-9339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"e-rbgo86"}}